|
Sign In to gain access to subscriptions and/or personal tools.
|
Chairmen's introduction
Paolo Brunetti
Bernard Charbonnel
References
- Turner RC, Cull CA, Frighi V., Holman RR for the UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281:2005-12.[Abstract/Free Full Text]
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Isomaa B., Almgren P., Tuomi T. et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24: 683-9.[Abstract/Free Full Text]
The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 1 suppl,
S3 (2002)
DOI: 10.1177/14746514020020010101

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|